Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,666   1.18  Index Moved Down -0.07%
DIM GBT EMG DGM Basic Utilities Money Funds Utilities Market Drivers 
United States GSPC USD ...  |  Screen Global Equities


Processing
Collecting data for DGM

Diagnostic valuation

 
 Companies |  Insiders  | Dashboard  
     

Diagnostic Medical S

Stock@Paris Stock Exchange 
France EUR
     
Use Diagnostic Medical Systems Soci (#FR0000063224FR) valuation together with your stock portfolios to protect against small markets fluctuations and to determine Stock optimization strategy that fits your criteria.  Suggest Portfolio
Diagnostic Medical Systems Soci is currently anticipated to have takeover price of 8.2 M with market capitalization of 10.9 M, debt of 2.63 M, and cash on hands of 5.32 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Diagnostic fundamentals before making investing decisions based on the enterprise value of the company
Takeover PriceMarket CapDebt ObligationsCash
8.2 M10.9 M2.63 M5.32 M

Diagnostic Investor Information

The company has price-to-book (P/B) ratio of 0.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. Diagnostic Medical Systems Soci had not issued any dividends in recent years. Diagnostic Medical Systems Soci?t? Anonyme engages in the manufacture and distribution of imaging systems for conventional and digital radiology, and bone densitometry applications worldwide. To learn more about DMS call Jean-Paul Ansel at 33 4 67 50 49 00 or check out http://www.dms.com.

Diagnostic Asset Utilization

Diagnostic Medical Systems Soci possesses negative operation of assets of -1.29 percent, realizing only ?0.01 for each euro of assets held by the firm. Discouraging assets utilization signifies that the company is being less effective with each euro of assets it possesses. In plain English assets utilization of Diagnostic Medical Systems Soci shows how wasteful it operates for each euro spent on its assets

Diagnostic Profitability Analysis

The company reported revenue of 26.31 M. Net Loss for the year was (1.76 M) with profit before overhead, payroll, taxes, and interest of 4 M.

Diagnostic Debt Analysis

DMS has accumulated about 5.32 M in cash with (3.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
The company has accumulated 2.63 M in total debt with debt to equity ratio (D/E) of 0.19 which may suggest the company is not taking enough advantage from borrowing. Diagnostic Medical Systems Soci has Current Ratio of 1.9 which is within standard range for the sector.

Diagnostic Market Share

Diagnostic Medical Systems Soci is rated # 5 in market capitalization category among related companies. Market capitalization of Medical Appliances and Equipment industry is currently estimated at about 1.92 Billion. Diagnostic maintains roughly 10.9 Million in market capitalization contributing less than 1% to all equities under Medical Appliances and Equipment industry.
Follow Diagnostic Valuation with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Diagnostic to your reader
 

Diagnostic Revenue

Based on latest financial disclosure Diagnostic Medical Systems Soci reported 26.31 M of revenue. This is 99.42% lower than that of Healthcare sector, and 98.57% lower than that of Medical Appliances and Equipment industry, The Revenue for all stocks is 99.67% higher than the company.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium